X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tenecteplase (421) 421
humans (241) 241
thrombolysis (134) 134
index medicus (128) 128
male (123) 123
female (119) 119
fibrinolytic agents - therapeutic use (119) 119
alteplase (115) 115
tissue plasminogen activator - therapeutic use (110) 110
middle aged (107) 107
aged (100) 100
thrombolytic therapy (100) 100
treatment outcome (93) 93
cardiac & cardiovascular systems (75) 75
acute myocardial-infarction (74) 74
peripheral vascular disease (74) 74
stroke (71) 71
myocardial infarction - drug therapy (69) 69
randomized-trial (69) 69
tissue plasminogen activator - administration & dosage (64) 64
fibrinolytic agents - administration & dosage (62) 62
pulmonary embolism (60) 60
therapy (60) 60
tissue-plasminogen-activator (60) 60
reteplase (58) 58
thrombolytic therapy - methods (56) 56
clinical neurology (55) 55
care and treatment (53) 53
mortality (52) 52
drug therapy (46) 46
heart attack (43) 43
stroke - drug therapy (43) 43
fibrinolysis (42) 42
research (42) 42
tissue-plasminogen activator (42) 42
trial (42) 42
myocardial infarction (41) 41
tissue plasminogen activator (41) 41
heart attacks (40) 40
management (40) 40
electrocardiography (39) 39
fibrinolytic agents - adverse effects (39) 39
thrombosis (39) 39
adult (38) 38
medicine, general & internal (38) 38
reperfusion (37) 37
time factors (36) 36
efficacy (35) 35
ischemia (35) 35
medicine & public health (35) 35
pharmacology & pharmacy (35) 35
cardiology (34) 34
myocardial infarction - therapy (34) 34
safety (34) 34
tissue plasminogen activator - adverse effects (34) 34
drug therapy, combination (33) 33
hematology (33) 33
streptokinase (33) 33
acute ischemic-stroke (32) 32
pulmonary embolism - drug therapy (30) 30
percutaneous coronary intervention (29) 29
fibrinolytic therapy (28) 28
myocardial infarction - mortality (28) 28
risk factors (28) 28
analysis (27) 27
abridged index medicus (26) 26
acute myocardial infarction (26) 26
brain ischemia - drug therapy (26) 26
aged, 80 and over (25) 25
animals (25) 25
health aspects (25) 25
anticoagulants (24) 24
dosage and administration (24) 24
heparin (24) 24
thrombolytic therapy - adverse effects (24) 24
unfractionated heparin (24) 24
medical research (23) 23
cardiovascular (22) 22
clinical trials (22) 22
front-loaded alteplase (22) 22
primary angioplasty (22) 22
abciximab (21) 21
angioplasty (21) 21
angioplasty, balloon, coronary (21) 21
medicine, experimental (21) 21
prospective studies (21) 21
enoxaparin (20) 20
myocardial infarction - diagnosis (20) 20
patients (20) 20
randomized controlled trials as topic (20) 20
thrombectomy (20) 20
anticoagulants - therapeutic use (19) 19
diagnosis (19) 19
fibrinolytic agents - pharmacology (19) 19
neurosciences (19) 19
retrospective studies (19) 19
studies (19) 19
cardiac patients (18) 18
desmoteplase (18) 18
diseases of the circulatory system (18) 18
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (417) 417
French (15) 15
Russian (11) 11
German (8) 8
Portuguese (3) 3
Spanish (3) 3
Japanese (2) 2
Persian (2) 2
Italian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurology, ISSN 0028-3878, 06/2019, Volume 92, Issue 23, pp. 1075 - 1076
Journal Article
by Zhang, Y and Hou, J and Wang, LY
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, ISSN 1128-3602, 10/2016, Volume 20, Issue 20, pp. 4369 - 4379
OBJECTIVE: To evaluate the clinical efficacy between tenecteplase (TNK) and alteplase (rt-PA). Furthermore, suitable dosage of TNK in cerebral arterial... 
Clinical efficacy | FRONT-LOADED ALTEPLASE | REDUCED-DOSE TENECTEPLASE | RANDOMIZED-TRIAL | Dosage | COMBINATION | Meta-analysis | EPTIFIBATIDE | Alteplase | SINGLE-BOLUS TENECTEPLASE | ACUTE ISCHEMIC-STROKE | ACUTE MYOCARDIAL-INFARCTION | DOUBLE-BLIND | THROMBOLYSIS | PHARMACOLOGY & PHARMACY | Tenecteplase
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 08/2018, Volume 169, Issue 4, pp. JC20 - JC20
Journal Article
Stroke, ISSN 0039-2499, 08/2019, Volume 50, Issue 8, pp. 2156 - 2162
BACKGROUND AND PURPOSE—TNK (tenecteplase), a newer fibrinolytic agent, has practical delivery advantages over ALT (alteplase) that would make it a useful agent... 
fibrinolytic agent | THERAPY | myocardial infarction | THROMBOLYSIS | PERIPHERAL VASCULAR DISEASE | half-life | tissue-type plasminogen activator | tenecteplase | CLINICAL NEUROLOGY
Journal Article
Revue Neurologique, ISSN 0035-3787, 12/2015, Volume 171, Issue 12, pp. 866 - 875
New therapeutic strategies are under evaluation to improve the treatment of acute ischemic stroke (AIS). Approaches combining intravenous (IV) thrombolysis... 
Desmoteplase | Antithrombotics | Ischemic stroke | Tenecteplase | Thrombolysis
Journal Article
Iranian biomedical journal, ISSN 1028-852X, 07/2019, Volume 23, Issue 4, pp. 272 - 279
The expression of bio-therapeutic proteins in mammalian cells, such as CHO, attains high homogeneity related to post-translational modifications. Although CHO... 
Leishmania tarentolae | Tenecteplase | Tissue plasminogen activator | Full Length
Journal Article
Clinical and Applied Thrombosis/Hemostasis, ISSN 1076-0296, 09/2015, Volume 21, Issue 6, pp. 550 - 557
Journal Article
NEUROLOGY ASIA, ISSN 1823-6138, 09/2019, Volume 24, Issue 3, pp. 203 - 208
Background & Objective: The Indian data comparing the efficacy and safety outcomes of tenecteplase and alteplase in acute ischemic stroke is scarce. We aimed... 
Alteplase | safety | thrombolysis | OPEN-LABEL | stroke | tenecteplase | efficacy | CLINICAL NEUROLOGY
Journal Article
Indian Heart Journal, ISSN 0019-4832, 2013, Volume 65, Issue 4, pp. 436 - 441
Objective: To study the efficacy and safety of single intravenous bolus administration of indigenously developed tenecteplase (TNK-tPA) in the management of... 
STEMI | Prescription-event monitoring | Tenecteplase
Journal Article
Journal Article
Stroke, ISSN 0039-2499, 05/2019, Volume 50, Issue 5, pp. 1279 - 1281
BACKGROUND AND PURPOSE—Tenecteplase represents a promising alternative to alteplase as thrombolytic treatment in acute ischemic stroke. There are limited data... 
brain ischemia | PLASMINOGEN-ACTIVATOR | PERIPHERAL VASCULAR DISEASE | OPEN-LABEL | alteplase | stroke | tissue-type plasminogen activator | tenecteplase | CLINICAL NEUROLOGY | Stroke (Disease) | Tenecteplase | Drug therapy | Patient outcomes | Testing
Journal Article
Stroke, ISSN 0039-2499, 02/2019, Volume 50, Issue 2, pp. 498 - 500
BACKGROUND AND PURPOSE—Thrombolysis with alteplase has beneficial effect on outcome and is safe within 4.5 hours. The present study compares the efficacy and... 
mortality | odds ratio | intention to treat analysis | intracranial hemorrhages | tenecteplase | Stroke (Disease) | Patient outcomes | Dosage and administration | Tenecteplase | Thrombolytic drugs | Comparative analysis | Drug therapy
Journal Article
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, ISSN 1735-0328, 2019, Volume 18, Issue 3, pp. 1622 - 1631
Acute myocardial infarction (AMI) is the leading cause of death throughout the world. One of the standard approaches to treatment of AMI is fibrinolysis. The... 
Network meta-analysis | PRIMARY CORONARY ANGIOPLASTY | TISSUE-PLASMINOGEN ACTIVATOR | CARDIOLOGY | Clinical efficacy | FRONT-LOADED ALTEPLASE | EUROPEAN-SOCIETY | Tenecteplase, Reteplase | IMMEDIATE ANGIOPLASTY | HEART-DISEASE | Alteplase | SINGLE-BOLUS TENECTEPLASE | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | Acute myocardial infarction | THROMBOLYTIC THERAPY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 12, pp. 1099 - 1107
Journal Article
Circulation, ISSN 0009-7322, 06/2016, Volume 133, Issue 23, pp. 2279 - 2286
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.